U.S. flag

An official website of the United States government

NM_001042492.3(NF1):c.7153AACTTT[1] (p.2385NF[1]) AND Neurofibromatosis, type 1

Germline classification:
Pathogenic/Likely pathogenic (6 submissions)
Last evaluated:
Jan 5, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000206539.22

Allele description [Variation Report for NM_001042492.3(NF1):c.7153AACTTT[1] (p.2385NF[1])]

NM_001042492.3(NF1):c.7153AACTTT[1] (p.2385NF[1])

Gene:
NF1:neurofibromin 1 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
17q11.2
Genomic location:
Preferred name:
NM_001042492.3(NF1):c.7153AACTTT[1] (p.2385NF[1])
HGVS:
  • NC_000017.11:g.31343099AACTTT[1]
  • NG_009018.1:g.253123AACTTT[1]
  • NM_000267.3:c.7090AACTTT[1]
  • NM_000267.3:c.7096_7101del
  • NM_001042492.3:c.7153AACTTT[1]MANE SELECT
  • NP_000258.1:p.2364NF[1]
  • NP_001035957.1:p.2385NF[1]
  • LRG_214t1:c.7090AACTTT[1]
  • LRG_214:g.253123AACTTT[1]
  • LRG_214p1:p.2364NF[1]
  • NC_000017.10:g.29670116_29670121del
  • NC_000017.10:g.29670117AACTTT[1]
  • NM_000267.3:c.7096_7101del
  • NM_000267.3:c.7096_7101delAACTTT
  • NM_001042492.2:c.7159_7164del
  • NM_001042492.2:c.7159_7164del6
  • NM_001042492.3:c.7153AACTTT[1]
Links:
dbSNP: rs864622639
NCBI 1000 Genomes Browser:
rs864622639
Molecular consequence:
  • NM_000267.3:c.7090AACTTT[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001042492.3:c.7153AACTTT[1] - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Name:
Neurofibromatosis, type 1 (NF1)
Synonyms:
NEUROFIBROMATOSIS, TYPE I; Recklinghausen's disease; Von Recklinghausen disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0018975; MedGen: C0027831; Orphanet: 636; OMIM: 162200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000261489Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 5, 2024)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

SCV000782100Center for Human Genetics, Inc, Center for Human Genetics, Inc
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 1, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001218929Medical Genetics, University of Parma
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Dec 20, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001479216Genome Diagnostics Laboratory, The Hospital for Sick Children
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 26, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002560558Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Mar 15, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003837582Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 9, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.

Abernathy CR, Colman SD, Kousseff BG, Wallace MR.

Hum Mutat. 1994;3(4):347-52.

PubMed [citation]
PMID:
8081387

Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD.

Hum Mutat. 2000;15(6):541-55.

PubMed [citation]
PMID:
10862084
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000261489.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This variant, c.7096_7101del, results in the deletion of 2 amino acid(s) of the NF1 protein (p.Asn2366_Phe2367del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with neurofibromatosis (PMID: 8081387, 10862084, 18546366, 24789688). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 220715). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Center for Human Genetics, Inc, Center for Human Genetics, Inc, SCV000782100.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Medical Genetics, University of Parma, SCV001218929.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genome Diagnostics Laboratory, The Hospital for Sick Children, SCV001479216.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV002560558.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, SCV003837582.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024